US EditionAustrian startup aTENSION.life debuts with €2.6M to tackle undiagnosed hypertension - Silicon Canals
Summary by Silicon Canals
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Austrian startup aTENSION.life debuts with €2.6M to tackle undiagnosed hypertension - Silicon Canals
Vienna-based aTENSION.life, a high-tech life science startup, announced its launch to transform hypertension treatment, utilising its proprietary ALDO+ technology platform. In addition to the launch, the Austrian company also secured $3M (approximately €2.6M) in a seed round led by Wlanholding, with eQventure and VP Venture Partners also participating. “Every hypertension patient deserves an early and precise diagnosis leading to a targeted trea…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
